Boehringer to sponsor patient iPad app

Boehringer Ingelheim and Visible Health have entered into a collaboration where the global pharma company will sponsor Visible Health’s series of drawMD Cardiology patient education iPad apps.

drawMD 3 allows doctors to create visual images that can be used to guide conversations about medical and surgical conditions and procedures with their patients. The app has recently been updated to drawMD 3.

“Boehringer Ingelheim is continuously searching for new and innovative ways to help improve the lives of patients and we believe improving the patient-physician dialogue is crucial to successful patient care. The drawMD platform enhances this communication and we are excited to collaborate with a leader in this space.”

Jon Doniger, director of eBusiness, Boehringer Ingelheim Pharmaceuticals, Inc.

“As physicians, we conceived and built this tool for medical professionals to advance the patient education experience at the point of care. The latest updates to the cardiology app have been made in response to requests from our clinician users, as well as from our own experience using drawMD. drawMD was built by doctors for doctors with the goal of supporting a more efficient, but also a more effective patient-physician encounter. With the introduction of Visible Health Connect, we can begin to operationalize and enhance patient-clinician collaboration on a larger scale.”

Dr. Alexander Kutikov, Urologic Oncologist and co-founder of Visible Health.

The application is available for iPad users free-of-charge through the Apple iTunes App Store.


Reference links:

Visible Health press release

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.